SCHEMBL19786204

SCHEMBL19786204

Brc1ccc(-n2c(-c3ccccc3)nc3c4ccccc4c4ccccc4c32)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
GAA P10253 3/20 0.43
RXFP1 Q9HBX9 1/20 0.41
GRM1 Q13255 1/20 0.40
PI4KA P42356 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSP90AA1 P07900 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2585957 0.94 DHFR (0.50) DHFRMAPTMEN1KMT2AGAA
SCHEMBL29697348 0.94 DHFR (0.50) DHFRMAPTMEN1KMT2AGAA
SCHEMBL16724460 0.92 KMT2A (0.44) DHFRMAPTMEN1KMT2AGAA
SCHEMBL19013383 0.91 CYP2C19 (0.46) DHFRMAPTMEN1KMT2AGAA
SCHEMBL2586996 0.90 MAPT (0.52) DHFRMAPTMEN1KMT2AGAA
SCHEMBL21195750 0.89 MEN1 (0.48) DHFRMAPTMEN1KMT2AGAA
SCHEMBL31109976 0.89 MEN1 (0.48) DHFRMAPTMEN1KMT2AGAA
SCHEMBL2631757 0.89 MEN1 (0.48) DHFRMAPTMEN1KMT2AGAA
SCHEMBL19012993 0.88 MAPT (0.41) DHFRMAPTMEN1KMT2AGAA
SCHEMBL19012896 0.88 MAPT (0.41) DHFRMAPTMEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11133477-B2 Heterocyclic compound and organic light emitting element using same LT MATERIALS CO., LTD. (KR) 2021-09-28 US disclosed
US-20190312211-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2019-10-10 US disclosed
WO-2018012845-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME 희성소재(주) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11133477-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, CYP1A1 DHFR 813/4885MAPT 3027/4885MEN1 555/4885
US-20190312211-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, CYP1A1 DHFR 813/4885MAPT 3027/4885MEN1 555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.